TELA Bio to Announce Q3 2025 Results, Host Investor Call November 13

TELA Bio

MALVERN, PATELA Bio, Inc. (NASDAQ: TELA) announced it will release its third-quarter 2025 financial results on Thursday, November 13, 2025, followed by a conference call and webcast at 4:30 p.m. ET to discuss the company’s performance and provide a corporate update.

Investors can register online to join the live call. Participants are encouraged to register in advance or at least 15 minutes before the event begins. A live webcast and replay will be available through the Events & Presentations page of the investor section of TELA Bio’s website.

READ:  Omega Flex Reports Lower Q3 Sales and Profit Amid Housing Market Headwinds

TELA Bio is a commercial-stage medical technology company developing solutions designed to improve soft-tissue reconstruction outcomes. The company focuses on innovations that support natural healing and reduce reliance on permanent synthetic materials. Its portfolio aims to provide surgeons with effective, anatomically preserving options that deliver both clinical and economic value.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.